Acute and long term results of unprotected left main stenting using drug eluting stents

Cardiology Journal

Volumn 18, Issue 2, 2011, Pages 165-170

  Tzifos, Vaios ^a   Gatsis, Aristotelis ^a   Gerasimou, Argyrios ^a   Chatzis, Dimitrios ^a   Theodorakis, Georgios ^a  

^a HENRY DUNANT HOSPITAL   (Greece)

Author keywords

Coronary artery disease; Left main coronary disease; Percutaneous transluminal coronary angioplasty

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; EVEROLIMUS; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; HIRULOG; PACLITAXEL; RAPAMYCIN; ZOTAROLIMUS;

AGED; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOGENIC SHOCK; CHRONIC KIDNEY FAILURE; CONGESTIVE HEART FAILURE; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY STENT; DIABETES MELLITUS; DRUG ELUTING STENT; EVENT FREE SURVIVAL; FAMILY HISTORY; FEMALE; HEART DEATH; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE REVASCULARIZATION; HUMAN; HYPERTENSION; INTRAVASCULAR ULTRASOUND; LEFT CORONARY ARTERY; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE REPLACEMENT; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; RISK FACTOR; SMOKING; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STABLE ANGINA PECTORIS; STENT THROMBOSIS; UNSTABLE ANGINA PECTORIS;

AGED; AGED, 80 AND OVER; ANGINA, STABLE; ANGINA, UNSTABLE; ANGIOPLASTY, BALLOON, CORONARY; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; DISEASE-FREE SURVIVAL; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RISK FACTORS; TIME; TREATMENT OUTCOME;

EID: 79952853264     PISSN: 18975593     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Poloński L. Who is going to take the left mains? Cardiol J, 2007; 14: 6-10.
2. Bollati M, Gerasimou A, Sillano D et al. Results of percutaneous drug-eluting stent implantation for unprotected left main coronary disease according to left ventricular systolic function. Catheter Cardiovasc Interv, 2010; 75: 586-593.
3. Chieffo A, Stankovic G, Bonizzoni E et al. Early and mid-term results of drug-eluting stent implantation in unprotected left main. Circulation, 2005; 111: 791-795.
4. Park S, Kim Y, Lee B et al. Sirolimus-eluting stent implantation for unprotected left main coronary artery stenosis: Comparison with bare metal stent implantation. J Am Coll Cardiol, 2005; 45: 351-356.
5. Hill RA, Dundar Y, Bakhai A, Dickson R, Walley T. Drug-eluting stents: An early systematic review to inform policy. Eur Heart J, 2004; 25: 902-919.
6. Sukiennik A, Ostrowska-Nowak J, Wiśniewska-Szmyt J et al. Predicted and observed in-hospital mortality after left main coronary artery stenting in 204 patients. Cardiol J, 2008; 15: 268-276.
7. Huang HW, Brent BN, Shaw RE. Trends in percutaneous versus surgical revascularization of unprotected left main coronary stenosis in the drug-eluting stent era: A report from the American College of Cardiology-National Cardiovascular data registry (ACC-NCDR). Catheter Cardiovasc Interv, 2006; 68: 867-872.
8. Chieffo A, Park SJ, Valgimigli M et al. Favorable long-term outcome after drug-eluting stent implantation in nonbifurcation lesions that involve unprotected left main coronary artery. A multicenter registry. Circulation, 2007; 116: 158-162.
9. Biondi-Zoccai GGL, Agostoni P, Moretti C, Melliga E, Sheiban I. Making sense of the recent meta-analytical confusion concerning the safety of drug eluting stents. EuroIntervention, 2007; 3: 381-385.
10. Valgimigli M, van Mieghem C, Ong A et al. Short and long term clinical outcome after drug-eluting stent implantation for the percutaneous treatment of left main coronary artery disease: Insights from the Rapamycin-Eluting and Taxus Stent Evaluated At Rotterdam Cardiology Hospital registries (RESEARCH and T-SEARCH). Circulation, 2005; 111: 1383-1389.
11. Lee M, Kapoor N, Jamal F et al. Comparison of coronary artery bypass surgery with percutaneous coronary intervention with drug-eluting stents for unprotected left main coronary artery disease. J Am Coll Cardiol, 2006; 47: 864-870.
12. Price M, Cristea E, Sawhney N et al. Serial angiographic followup of sirolimus-eluting stents for unprotected left main coronary artery revascularization. J Am Coll Cardiol, 2006; 47: 971-977.
13. Wood F, Bazemore E, Schneider JE et al. Technique of the left main stenting is dependent on lesion location and distal branch protection. Catheter Cardiovasc Interv, 2005; 65: 499-503.
14. Migliorini A, Moschi G, Giurlani L et al. Drug-eluting stent supported percutaneous coronary intervention for unprotected left main disease. Catheter Cardiovasc Interv, 2006; 68: 225-230.
15. Sanmartin M, Baz J, Lozano I et al. One-year results of unprotected left main disease treatment with paclitaxel-eluting stents: Results of a multi-center registry. Catheter Cardiovasc Interv, 2007; 69: 372-377.
16. Fajadet J, Serrys P, Colombo A, Sheiban I, Seabra-Games R, Barragan P. Clinical and angiographic outcomes one year after elective implantation of sirolimus-eluting stents in unprotected left main coronary arteries: Final results of an European retrospective multi-center study. Am J Cardiol, 2006: suppl. 30M (abstract).
17. Lefevre T, Darremont O, Morice M. One-year outcome of the left main TAXUS pilot study. Am J Cardiol, 2006; 98: suppl. 29M (abstract).
18. Chieffo A, Morici N, Maisano F et al. Percutaneous treatment with drug-eluting stent implantation versus bypass surgery for unprotected left main stenosis: A single-center experience. Circulation, 2006; 113: 2542-2547.
19. Nashef S, Roques F, Michael P et al. The EuroSCORE study group. European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg, 1999; 16: 9-13.
20. Nashef S, Roques F, Hammill B et al. Validation of the European system for cardiac operation risk evaluation (EuroSCORE) in North American surgery. Eur J DV Surg, 2002; 22: 101-105.
21. Smith SC Jr, Feldman TE, Hirshfeld JW Jr et al. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention-Summary article: A report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). Circulation, 2006; 113: 156-175.